Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial by Deborah D Stocken, Klaus K Witte, Judith E Lowry, Rowena Byrom, Richard G Gillott, Hemant Chumun, Richard M Cubbon, David A Cairns, Mark T Kearney

Get full text

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction by Sam Straw, Melanie McGinlay, Samuel D. Relton, Aaron O. Koshy, John Gierula, Maria F. Paton, Michael Drozd, Judith E Lowry, Charlotte Cole, Richard M Cubbon, Klaus K. Witte, Mark T. Kearney

Get full text

Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial. by Maria F Paton, John Gierula, Judith E Lowry, David A Cairns, Kieran Bose Rosling, Charlotte A Cole, Melanie McGinlay, Sam Straw, Rowena Byrom, Richard M Cubbon, Mark T Kearney, Klaus K Witte

Get full text

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction by Ben N. Mercer, Aaron Koshy, Michael Drozd, Andrew M. N. Walker, Peysh A. Patel, Lorraine Kearney, John Gierula, Maria F. Paton, Judith E. Lowry, Mark T. Kearney, Richard M. Cubbon, Klaus K. Witte

Get full text

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure by John Gierula, Charlotte A. Cole, Michael Drozd, Judith E. Lowry, Sam Straw, Thomas A. Slater, Maria F. Paton, Rowenna J. Byrom, Ellis Garland, Georgia Halliday, Sarah Winsor, Gemma K. Lyall, Karen Birch, Melanie McGinlay, Emma Sunley, Peter J. Grant, David H. Wessels, Elias M. Ketiar, Klaus K. Witte, Richard M. Cubbon, Mark T. Kearney

Get full text